Skip to main content

Table 2 Characteristics of included studies (variables and impact expressed in terms of odds ratios extracted from included studies)

From: Male partner involvement in increasing the uptake of infant antiretroviral prophylaxis/treatment in sub Saharan Africa: A systematic review and meta-analysis

Author

Study population

Study design

Approach used

Degree of male involvement

Unadjusted OR

Aliyu et al. 2016 [35]

364 HIV positive mothers and infants Nigeria

RCT

Complex community interventions

Antenatal clinic(ANC) attendance

3.04 (1.16–5.47)

Becker et al. 2010 [30]

81 HIV positive mothers and infants in Tanzania

RCT

Invitation letter

ANC attendance couple voluntary counselling and testing

4.31 (3.46–5.37)

Byamugisha et al. 2010 [36]

1713 HIV positive mothers and infants in Uganda

Cohort

Complex community interventions

Couple voluntary counselling and testing

1.35 (1.08–1.68)

Conkling et al. 2010 [29]

185 HIV positive mothers for each centre in Zambia

Cohort

Invitation letter

Couple voluntary counselling and testing

1.08 (0.73–1.57)

Conkling et al. 2010 [29]

185 HIV positive mothers a for each centre in Rwanda

Cohort

Invitation letter

Couple voluntary counselling and testing

1.21 (0.66–2.23)

Farquhar et al. 2004 [33]

217 HIV positive women and their infants in Kenya

Cohort

Enhanced psychosocial intervention

ANC attendance couple voluntary counselling and testing

3.4 (1.3–9.0)

Kalembo et al. 2013 [31]

476 HIV positive women and their infants in Malawi

Cohort

Verbal encouragement

HIV counselling and testing, HIV status disclosure and support to adhere to protocols

1.4 (0.5–3.8)

Peltzer et al. 2010 [32]

745 HIV positive mothers and infants in South Africa

Cohort

Verbal encouragement

ANC attendance

2.95 (2.03–4.3)

Weiss et al. 2014 [34]

25 HIV positive mothers and infants in South Africa

RCT

Enhanced psychosocial intervention

ANC attendance couple voluntary counselling and testing

4.0 (0.36–44.7)

  1. ANC Antenatal clinic, RCT Randomized controlled trial, HIV Human Immunodeficiency Virus